GRAdHIVNE1
HIV Prevention
Phase 1Active
Key Facts
About ReiThera
ReiThera is a dual-focus Italian biotech, functioning both as a specialized CDMO for viral vectors and as a developer of its own therapeutic candidates. Its core expertise lies in viral vector engineering and scalable GMP manufacturing for adenoviruses, AAV, Lentivirus, MVA, and Herpes Simplex vectors. The company is advancing a clinical-stage HIV vaccine candidate in partnership with major research institutes and is actively involved in outbreak response efforts, such as for Marburg virus, while serving a global client base from its state-of-the-art facility in Rome.
View full company profileTherapeutic Areas
Other HIV Prevention Drugs
| Drug | Company | Phase |
|---|---|---|
| Cabotegravir (LA) for PrEP | ViiV Healthcare | Approved/Phase 3 |
| srRNA Vaccine for HIV | Replicate Bioscience | Pre-clinical |